Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debabrata Mukherjee

Showing results (1-10 of 573) with videos related to

Pageof 58
Sort By:
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 8, 2020
Cardiovascular and Hematological Medicine in 2020 - Advances and InsightsDebabrata Mukherjee
Lancet (London, England)|June 14, 2011
Antithrombotics and stent type for primary PCIDebabrata Mukherjee
Annals of Internal Medicine|September 16, 2015
Review: After coronary DES placement, longer vs shorter DAPT increases major bleeding and death and reduces MIDebabrata Mukherjee
Indian Heart Journal|January 6, 2009
Designing and performing large multicenter randomized clinical trials in India: what do we need?Debabrata Mukherjee
Cardiovascular & Hematological Agents in Medicinal Chemistry|January 24, 2012
Keeping up with advances in cardiovascular and hematological medicine in 2012Debabrata Mukherjee
JAMA Network Open|February 15, 2020
Coronary Revascularization in the United States-Patient Characteristics and Outcomes in 2020Debabrata Mukherjee
Biochemical Pharmacology|March 26, 2002
Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular eventsDebabrata Mukherjee
Cardiovascular & Hematological Agents in Medicinal Chemistry|December 15, 2012
Cardiovascular and Hematological Medicine in 2013 - Advances and InsightsDebabrata Mukherjee
Congestive Heart Failure (Greenwich, Conn.)|April 11, 2008
Nonsteroidal anti-inflammatory drugs and the heart: what is the danger?Debabrata Mukherjee
European Heart Journal|September 11, 2019
Tailoring strategies to optimize ischaemic benefit vs. bleeding risk in individuals post-myocardial infarctionDebabrata Mukherjee
Pageof 58

Showing results (1-10 of 573) with videos related to

Sort By:
Pageof 58
Cardiovascular & Hematological Agents in Medicinal Chemistry|May 8, 2020
Cardiovascular and Hematological Medicine in 2020 - Advances and InsightsDebabrata Mukherjee
Lancet (London, England)|June 14, 2011
Antithrombotics and stent type for primary PCIDebabrata Mukherjee
Annals of Internal Medicine|September 16, 2015
Review: After coronary DES placement, longer vs shorter DAPT increases major bleeding and death and reduces MIDebabrata Mukherjee
Indian Heart Journal|January 6, 2009
Designing and performing large multicenter randomized clinical trials in India: what do we need?Debabrata Mukherjee
Cardiovascular & Hematological Agents in Medicinal Chemistry|January 24, 2012
Keeping up with advances in cardiovascular and hematological medicine in 2012Debabrata Mukherjee
JAMA Network Open|February 15, 2020
Coronary Revascularization in the United States-Patient Characteristics and Outcomes in 2020Debabrata Mukherjee
Biochemical Pharmacology|March 26, 2002
Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular eventsDebabrata Mukherjee
Cardiovascular & Hematological Agents in Medicinal Chemistry|December 15, 2012
Cardiovascular and Hematological Medicine in 2013 - Advances and InsightsDebabrata Mukherjee
Congestive Heart Failure (Greenwich, Conn.)|April 11, 2008
Nonsteroidal anti-inflammatory drugs and the heart: what is the danger?Debabrata Mukherjee
European Heart Journal|September 11, 2019
Tailoring strategies to optimize ischaemic benefit vs. bleeding risk in individuals post-myocardial infarctionDebabrata Mukherjee
Pageof 58